Three versus four cycles of neoadjuvant gemcitabine cisplatin for muscle invasive bladder cancer (MIBC). Meeting Abstract

sustainable development goals

publication date

  • May 20, 2021

webpage

published in

volume

  • 39

issue

  • 15